Product
Upifitamab
1 clinical trial
2 indications
Indication
Platinum-Resistant Ovarian CancerIndication
Non Small Cell Lung Cancer MetastaticClinical trial
A Phase 1b/2, First-in-Human, Dose Escalation and Expansion Study of XMT-1536 In Patients With Solid Tumors Likely to Express NaPi2bStatus: Active (not recruiting), Estimated PCD: 2023-05-31